image
Healthcare - Medical - Devices - NASDAQ - IL
$ 13.28
-0.45 %
$ 924 M
Market Cap
5.96
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one INMD stock under the worst case scenario is HIDDEN Compared to the current market price of 13.3 USD, InMode Ltd. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one INMD stock under the base case scenario is HIDDEN Compared to the current market price of 13.3 USD, InMode Ltd. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one INMD stock under the best case scenario is HIDDEN Compared to the current market price of 13.3 USD, InMode Ltd. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart INMD

image
$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
395 M REVENUE
-19.76%
113 M OPERATING INCOME
-42.49%
181 M NET INCOME
-8.41%
133 M OPERATING CASH FLOW
-24.97%
162 M INVESTING CASH FLOW
219.21%
-283 M FINANCING CASH FLOW
-5137.55%
77.9 M REVENUE
-20.42%
15.6 M OPERATING INCOME
-43.95%
18.2 M NET INCOME
-78.01%
14 M OPERATING CASH FLOW
-56.71%
75.5 M INVESTING CASH FLOW
-3.00%
-99.5 M FINANCING CASH FLOW
16.01%
Balance Sheet InMode Ltd.
image
Current Assets 714 M
Cash & Short-Term Investments 596 M
Receivables 41.1 M
Other Current Assets 76.9 M
Non-Current Assets 71.2 M
Long-Term Investments 700 K
PP&E 11.1 M
Other Non-Current Assets 59.5 M
75.92 %5.22 %9.79 %7.57 %Total Assets$785.7m
Current Liabilities 69.9 M
Accounts Payable 13.8 M
Short-Term Debt 2.51 M
Other Current Liabilities 53.6 M
Non-Current Liabilities 12 M
Long-Term Debt 5.31 M
Other Non-Current Liabilities 6.69 M
16.84 %3.07 %65.43 %6.49 %8.18 %Total Liabilities$81.9m
EFFICIENCY
Earnings Waterfall InMode Ltd.
image
Revenue 395 M
Cost Of Revenue 77.8 M
Gross Profit 317 M
Operating Expenses 205 M
Operating Income 113 M
Other Expenses -68.7 M
Net Income 181 M
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00395m(78m)317m(205m)113m69m181mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
80.31% GROSS MARGIN
80.31%
28.50% OPERATING MARGIN
28.50%
45.91% NET MARGIN
45.91%
25.76% ROE
25.76%
23.07% ROA
23.07%
19.79% ROIC
19.79%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis InMode Ltd.
image
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 181 M
Depreciation & Amortization 728 K
Capital Expenditures -669 K
Stock-Based Compensation 16.6 M
Change in Working Capital -7.07 M
Others 3.66 M
Free Cash Flow 132 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets InMode Ltd.
image
Wall Street analysts predict an average 1-year price target for INMD of $20.4 , with forecasts ranging from a low of $15 to a high of $27 .
INMD Lowest Price Target Wall Street Target
15 USD 12.95%
INMD Average Price Target Wall Street Target
20.4 USD 53.61%
INMD Highest Price Target Wall Street Target
27 USD 103.31%
Price
Max Price Target
Min Price Target
Average Price Target
282826262424222220201818161614141212Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership InMode Ltd.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 YOKNEAM, Israel , May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public letter dated May 9, 2025. prnewswire.com - 1 month ago
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program Believes the Board Should Immediately Resume and Accelerate Buybacks Asserts Board Should Remove Moshe Mizrahy as CEO of the Company MIAMI , May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to continue its stock repurchase program and to replace its CEO. prnewswire.com - 1 month ago
InMode to Present at Upcoming Investor Conferences and Events YOKNEAM, Israel , May 7, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences: BNP 3rd Annual Aesthetics Day Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer Format: Virtual fireside chat moderated by Navann Ty, Lead Equity Analyst and one-on-one meetings When: Monday, May 19, fireside chat at 11:00 am ET A live webcast of the presentation can be accessed here. prnewswire.com - 1 month ago
InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) InMode's Q1 2025 results disappointed, with revenue and EPS missing estimates, leading to a 12% stock drop and another potential guidance cut. Despite solid fundamentals and attractive valuation, weakening demand, no buybacks, and uncertain forecasts make me downgrade INMD from Buy to Hold. The company has high margins, lots of cash, and operates in a growing market, but short-term catalysts are lacking. seekingalpha.com - 2 months ago
InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) InMode's Q1 2025 earnings reveal a 3% YoY revenue decline and margin compression, signaling continued macroeconomic pressures and underutilization of installed platforms. Management's revised 2025 guidance lowers profitability expectations, reflecting ongoing challenges in the U.S. market and less profitable international expansion. Despite a strong balance sheet, past strategic missteps and ineffective cash allocation raise concerns about future shareholder value and growth prospects. seekingalpha.com - 2 months ago
Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City New York, New York--(Newsfile Corp. - April 28, 2025) -  Eyes On Park, a leading optometry practice in Gramercy Park, announces the introduction of the cutting-edge Envision by InMode system for comprehensive dry eye treatment. Dr. Irina Shiyan and her team now offer this advanced, non-invasive technology that combines Forma-I radiofrequency and Lumecca-I intense pulsed light therapies to address the root causes of dry eye disease, not just the symptoms. newsfilecorp.com - 2 months ago
InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript InMode Ltd. (NASDAQ:INMD ) Q1 2025 Earnings Conference Call April 28, 2025 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - CEO Yair Malca - CFO Conference Call Participants Matt Miksic - Barclays Danielle Antalffy - UBS Matt Taylor - Jefferies Caitlin Cronin - Canaccord Genuity Mike Matson - Needham & Company Sam Eiber - BTIG Dane Reinhardt - Baird Operator Good day, and welcome to InMode's First Quarter 2025 Earnings Results Conference Call. seekingalpha.com - 2 months ago
InMode (INMD) Lags Q1 Earnings Estimates InMode (INMD) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.45 per share a year ago. zacks.com - 2 months ago
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares  YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025. prnewswire.com - 2 months ago
Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 months ago
InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? InMode (INMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. zacks.com - 2 months ago
8. Profile Summary

InMode Ltd. INMD

image
COUNTRY IL
INDUSTRY Medical - Devices
MARKET CAP $ 924 M
Dividend Yield 0.00%
Description InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Contact Tavor Building, Yokne'am, 2069206 https://www.inmodemd.com
IPO Date Aug. 8, 2019
Employees 599
Officers Mr. Brandon Nye Vice President of Sales of West US Mr. Michael Dennison Vice President of Sales - East US Mr. Yair Malca Chief Financial Officer Dr. Michael Kreindel Co-Founder, Chief Technology Officer & Director Mr. Matt Rodgers Vice President of Sales of Canada Mr. Moshe Mizrahy Co-Founder, Chief Executive Officer & Director Ms. Nava Tal-Launer Chief Information Officer